Jia Ke
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 5%
- Cancer Cells and Metastasis
- Colorectal Cancer Surgical Treatments
Papers in
- Oncology 23
- Colorectal Cancer Surgical Treatments 7
- Cancer Cells and Metastasis 4
-
- Epigenetics and DNA Methylation 3
- Co-authors
- Xiaojian Wu (28 shared papers)Ping Lan (26 shared papers)Xiaosheng He (19 shared papers)Xianrui Wu (15 shared papers)Yifeng Zou (18 shared papers)Xiaofeng Jiang (7 shared papers)Feng Gao (12 shared papers)Ping Lan (9 shared papers)
- Journals
- Frontiers in Medicine (3 papers)Cancer Cell International (3 papers)International Journal of Surgery (2 papers)Diseases of the Colon & Rectum (2 papers)Surgical Endoscopy (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Jia Ke
84 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 116
- Cancer Research 272
- Oncology 429
- Otorhinolaryngology 47
- Health Informatics 13
- Molecular Biology 439
Countries citing papers authored by Jia Ke
This map shows the geographic impact of Jia Ke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jia Ke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jia Ke more than expected).
Fields of papers citing papers by Jia Ke
This network shows the impact of papers produced by Jia Ke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jia Ke. The network helps show where Jia Ke may publish in the future.
Co-authors
The 25 scholars most cited alongside Jia Ke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 92 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 142 | |
| 2 | 2012 | 137 | |
| 3 | 2023 | 76 | |
| 4 | 2017 | 75 | |
| 5 | 2018 | 64 | |
| 6 | 2010 | 51 | |
| 7 | 2013 | 50 | |
| 8 | 2021 | 49 | |
| 9 | 2017 | 49 | |
| 10 | 2015 | 44 | |
| 11 | 2012 | 40 | |
| 12 | 2013 | 40 | |
| 13 | 2021 | 38 | |
| 14 | PAF receptor antagonist Ginkgolide B inhibits tumourigenesis and angiogenesis in colitis-associated cancer. | 2015 | 37 |
| 15 | 2023 | 34 | |
| 16 | 2013 | 33 | |
| 17 | 2021 | 30 | |
| 18 | 2001 | 30 | |
| 19 | 2021 | 29 | |
| 20 | 2018 | 26 |
About Jia Ke
Jia Ke is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Genetics, having authored 92 papers that have together received 1.6k indexed citations. Recurring topics across this work include Ear Surgery and Otitis Media (7 papers), Colorectal Cancer Surgical Treatments (7 papers), Inflammatory Bowel Disease (7 papers), Cancer Cells and Metastasis (4 papers), Ferroptosis and cancer prognosis (4 papers), Epigenetics and DNA Methylation (3 papers), COVID-19 Clinical Research Studies (3 papers) and Cancer-related molecular mechanisms research (3 papers). The work is most often cited by research in Cancer Research (272 citations), Oncology (429 citations), Otorhinolaryngology (47 citations), Health Informatics (13 citations) and Molecular Biology (439 citations). Jia Ke has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xiaojian Wu, Ping Lan, Xiaosheng He, Xianrui Wu, Yifeng Zou, Xiaofeng Jiang, Feng Gao, Ping Lan, Yufeng Chen and Lei Lian. Their work appears in journals such as Frontiers in Medicine, Cancer Cell International, International Journal of Surgery, Diseases of the Colon & Rectum and Surgical Endoscopy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.